Federal Register / Vol. 74, No. 193 / Wednesday, October 7, 2009 / Notices 51609 

to ensure representativeness on 

important dimensions such as mine size 

and region of the country. Sampling a 

large proportion of the underground 

coal mines will ensure low rates of 

sampling error and increase confidence 

in the resulting survey estimates. Oversampling some types of mines, such as 

those operating longwall sections, will 

be necessary to ensure enough cases are 

available to conduct meaningful 

analysis of these mine types. 

Allowing mine operators to complete 

the survey using the method they find 

convenient is expected to enhance the 

overall response rate. Therefore, both a 

Web-based and a print version of the 

questionnaire will be provided to 

sampled respondents. Using these 

multiple methods of administration, 

NIOSH expects to achieve an 80% rate 

of response to the survey. In order to 

further reduce the overall burden on 

respondents, certain types of 

supplementary information (e.g., the 

mine’s dates of operation, annual coal 

production) will be gathered from 

publicly-available data collected by the 

Mine Safety and Health Administration 

(MSHA). 

Once the study is completed, NIOSH 

will provide a copy of the final report 

to each sampled mining operation, and 

use the survey data to improve the 

adoption of important safety and health 

practices throughout the coal mine 

industry. There is no cost to 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of response Number of 

respondents 

Number 

responses per 

respondent 

Average burden per 

response (in 

hours) 

Total burden 

hours 

Initial telephone contact with coal mines ......................................................... 300 1 5/60 25 

Respondents completing paper survey ........................................................... 144 1 30/60 72 

Respondents completing Web survey ............................................................. 96 1 25/60 40 

Total .......................................................................................................... ........................ ........................ ........................ 137 

Dated: September 30, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–24156 Filed 10–6–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–09–0021] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Maryam I. Daneshvar, 

CDC Acting Reports Clearance Officer, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

National Coal Workers’ Autopsy 

Study (NCWAS)—Extension—(0920– 

0021 exp. 1/31/2010) National Institute 

for Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention. 

Background and Brief Description 

Under the Federal Coal Mine Health 

and Safety Act of 1977, Public Law 91– 

173 (amended the Federal Coal Mine 

and Safety Act of 1969), the Public 

Health Service has developed a 

nationwide autopsy program (NCWAS) 

for underground coal miners. The 

Consent Release and History Form is 

primarily used to obtain written 

authorization from the next-of-kin to 

perform an autopsy on the deceased 

miner. Because a basic reason for the 

post-mortem examination is research 

(both epidemiological and clinical), a 

minimum of essential information is 

collected regarding the deceased miners, 

including occupational history and 

smoking history. The data collected will 

be used by the staff at NIOSH for 

research purposes in defining the 

diagnostic criteria for coal workers’ 

pneumoconiosis (black lung) and 

pathologic changes and will be 

correlated with x-ray findings. 

It is estimated that only 5 minutes is 

required for the pathologist to put a 

statement on the invoice affirming that 

no other compensation is received for 

the autopsy. From past experience, it is 

estimated that 15 minutes is required for 

the next-of-kin to complete the Consent 

Release and History Form. Since an 

autopsy report is routinely completed 

by a pathologist, the only additional 

burden is the specific request of abstract 

of terminal illness and final diagnosis 

relating to pneumoconiosis. Therefore, 

only 5 minutes of additional burden is 

estimated for the autopsy report. 

There are no costs to respondents 

other than their time. 


erowe on DSK5CLS3C1PROD with NOTICES
51610 Federal Register / Vol. 74, No. 193 / Wednesday, October 7, 2009 / Notices 

ESTIMATED ANNUALIZED BURDEN

Type of respondent Type of form Number 

of respondents 

Number of responses per 

respondent 

Average burden per 

response (in 

hrs.) 

Total burden 

(in hrs.) 

Pathologist ........................................ Pathologist Invoice ........................... 50 1 5/60 4 

Pathologist ........................................ Pathologist Report ............................ 50 l 5/60 4 

Next-of-Kin ........................................ Consent Form .................................. 50 1 15/60 13 

Total ........................................... ........................................................... ........................ ........................ ........................ 21 

Dated: September 30, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–24155 Filed 10–6–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–D–0430] 

Draft Guidance for Industry: 

Ingredients Declared as Evaporated 

Cane Juice; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of the draft guidance 

entitled ‘‘Guidance for Industry: 

Ingredients Declared as Evaporated 

Cane Juice.’’ The intent of this draft 

guidance is to advise industry of FDA’s 

view that the common or usual name for 

the solid or dried form of sugar cane 

syrup is ‘‘dried cane syrup,’’ and that 

sweeteners derived from sugar cane 

syrup should not be declared on food 

labels as ‘‘evaporated cane juice’’ 

because that term falsely suggests that 

the sweeteners are juice. 

DATES: Although you can comment on 

any guidance at any time (see 21 CFR 

10.115(g)(5)), to ensure that the agency 

considers your comment on the draft 

guidance before it begins work on the 

final version of the guidance, submit 

written or electronic comments on the 

draft guidance by December 7, 2009. 

ADDRESSES: Submit written comments 

on the draft guidance to the Division of 

Dockets Management (HFA–305), Food 

and Drug Administration, 5630 Fishers 

Lane, rm. 1061, Rockville, MD 20852. 

Submit electronic comments on the 

draft guidance to http:// 

www.regulations.gov. Submit written 

requests for single copies of the draft 

guidance to Office of Nutrition, 

Labeling, and Dietary Supplements, 

Center for Food Safety and Applied 

Nutrition (HFS–820), Food and Drug 

Administration, 5100 Paint Branch 

Pkwy., College Park, MD 20740. Send 

two self-addressed adhesive labels to 

assist that office in processing your 

request. See the SUPPLEMENTARY

INFORMATION section for electronic 

access to the draft guidance. 

FOR FURTHER INFORMATION CONTACT: 

Geraldine June, Center for Food Safety 

and Applied Nutrition (HFS–820), Food 

and Drug Administration, 5100 Paint 

Branch Pkwy., College Park, MD 20740, 

301–436–1802. 

SUPPLEMENTARY INFORMATION: 

I. Background 

FDA is announcing the availability of 

the draft guidance entitled ‘‘Guidance 

for Industry: Ingredients Declared as 

Evaporated Cane Juice.’’ The intent of 

this draft guidance is to advise the 

regulated industry of FDA’s view that 

the term ‘‘evaporated cane juice’’ is not 

the common or usual name of any type 

of sweetener, including dried cane 

syrup. Because cane syrup has a 

standard of identity defined by 

regulation in 21 CFR 168.130, the 

common or usual name for the solid or 

dried form of cane syrup is ‘‘dried cane 

syrup.’’ This guidance is being issued 

because the term ‘‘evaporated cane 

juice’’ has appeared on a number of food 

labels in recent years. FDA’s current 

policy is that sweeteners derived from 

sugar cane syrup should not be declared 

as ‘‘evaporated cane juice’’ because that 

term falsely suggests that the sweeteners 

are juice as defined in 21 CFR 120.1(a). 

FDA is issuing this draft guidance as 

a level 1 draft guidance consistent with 

FDA’s good guidance practices 

regulation (21 CFR 10.115). The draft 

guidance, when finalized, will represent 

the agency’s current thinking on the use 

of the terms ‘‘dried cane syrup’’ and 

‘‘evaporated cane juice’’ in food 

labeling. It does not create or confer any 

rights for or on any person and does not 

operate to bind FDA or the public. An 

alternate approach may be used if such 

approach satisfies the requirements of 

the applicable statutes and regulations. 

II. Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) written or electronic 

comments regarding the draft guidance. 

Submit a single copy of electronic 

comments or two paper copies of any 

mailed comments, except that 

individuals may submit one paper copy. 

Comments are to be identified with the 

docket number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

III. Electronic Access 

Persons with access to the Internet 

may obtain the draft guidance at http:// 

www.fda.gov/FoodGuidances or http:// 

www.regulations.gov. 

Dated: September 29, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–24132 Filed 10–6–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 


erowe on DSK5CLS3C1PROD with NOTICES